Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Tumor-like multiple sclerosis.
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Capture-Recapture as a Potentially Useful Procedure for Assessing Prevalence of Multiple Sclerosis: Methodologic Exercise Using Portuguese Data.
Serum level of interleukin-6 in Chinese patients with multiple sclerosis.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
ICV-transplanted human glial precursor cells are short-lived yet exert immunomodulatory effects in mice with EAE.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
The role of complementary and alternative medicine in therapy of multiple sclerosis.
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
Analysis of the Paired TCR α- and β-chains of Single Human T Cells.
Editorial for JNV issue on PML.
Assessment of confirmed urinary tract infection in patients treated with dalfampridine for multiple sclerosis.
Neuroprotective effects of riluzole in neurotrauma models: a review.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Ampyra (dalfampridine) medication guide
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
[Cannabinoid drugs for neurological diseases: what is behind?].
Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.

Pages